Pillstats
Rx only · Capsule, Gelatin Coated · Oral

Disopyramide Phosphate

Brands: Norpace · Disopyramide Phosphate

2 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US4 NDCs
2 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
ATCC01BA03
RxCUI (US)3541
US makers2 labelers
Packages4
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 2 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$0.353$0.706$1.06$1.41Dec 2025Apr 2026Jul 2026
$1.197
Latest avg · Jul 22, 2026
-2%
Since Dec 17, 2025
2
Active US suppliers
100%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

n/an/an/a122537492025 Q12025 Q22025 Q32025 Q42026 Q1
43
Rx · 2025 Q4
6.0K
Units dispensed
2
Quarters · since 2025 Q1

Who makes it2 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Pfizer Laboratories Div Pfizer Incunknown2SUPPLYING
Mylan Pharmaceuticals Inc.unknown2SUPPLYING

Regulatory & supply events

No recalls, shortages, or registration changes on record for this drug concept.